If you are interested in WGS analysis, check our pipeline to call SNV and CNV by integrating multiple callers on EP16.033

Congratulations to Ana Brito for achieving her masters degree on a novel biomimetic model to study hereditary diffuse gastric cancer developed at i3S-Instituto de Investigação e Inovação em Saúde and awarded by Instituto de Ciências Biomédicas Abel Salazar UP

Huge pleasure to have the input of HDGC patients on the development of the latest HDGC guidelines. More than numbers and samples, it is important to remember for whom we work everyday, for life-saving measures and overall better quality of life.

Don’t miss this journalistic piece on one Portuguese family carrying a founder #CDH1 variant with hereditary diffuse gastric cancer. A perfect example of when science helps save lives #HDGC

Joining the EUROoCS 2024 International Meeting.

Stay tuned this weekend 📣📣 for a journalistic piece on one Portuguese family carrying a CDH1 founder variant causing HDGC publico.pt/2024/08/17/cie…

#JoinUsOnline 📢 Can't attend our Midterm Conference in person? No worries! We've just opened our ONLINE attendance feature! How exciting! #EventAlert 🔗 Register Here: ec.europa.eu/eusurvey/runne… (Closing Date: September 30) 💡 More Information: preventable.eu/2024/06/21/pre…

Patient Resources for Hereditary Diffuse Gastric Cancer ccr.cancer.gov/surgical-oncol… For patients, their families, and practitioners looking for guidance. #CDH1 #HDGC #CTNNA1 Debbie's Dream Foundation: Curing Stomach Cancer HopeForStomachCancer StupidStrong NoStomachForCancer

Don’t miss Carla’s seminar on the socio-economic impact of hereditary cancer on Friday

Proud of Daniel Ferreira for being awarded a #CaixaImpulse Innovation project to identify biomarkers for early diagnosis in #HDGC using a stomach-on-chip model. This project has the potential to improve the pathways of care of gastric and breast cancer at-risk individuals

Delighted to be invited to speak at the CGA-IGC and present the latest updates of the IGCLC 2024 consensus meeting, which will generate the updated HDGC clinical guidelines. Stay tuned for this great meeting 📣📣

Happy to show our latest data on costs of prevention vs treatment of advanced HDGC-associated tumours. Preventive measures cost 6-fold less than treatment of advanced disease in patients with median overall survival of 2,5 months Preventable

Learn more about the #i3S projects that secured €100K in support from the #laCaixa program CaixaImpulse. 📰👀👇 #i3Sresearch #i3Sinnovation #peopleofi3S #funding #CaixaResearchFundlaCaixa #CaixaResearch noticias.up.pt/2024/10/21/pro…

📢 Calling all patients! Join our anonymous survey on Rare Tumour Risk Syndromes (RTRS) care pathways. 🕒 10 minutes 📅 Open until Oct 31, 2024 🔗 To participate: preventable.eu/2024/06/22/sur… Your insights matter! #RTRS #Healthcare #Survey #PatientCare #PREVENTABLE

ERiC group is at the #ASHG2024 Stay tuned for the pioneer works of Silvana Lobo on CTNNA1-related predisposition on Friday at 1:30pm of session 84 and Celina São José poster on regulatory elements and 3D chromatin solving the missing heritability in HDGC on Friday at 2:30pm

💜🌍 Today is Rare Disease Day! 🌍💜 Together, we stand with the 300 million people worldwide living with rare diseases. In uniting on this day we can raise awareness, advocate for change, and promote a more equitable future! ⚖️ Learn more: rarediseaseday.org

Join us today at 14:00 GMT to raise awareness to rare diseases with a webinar on “Solving the unsolved in rare diseases (Solve-RD)”